Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial.
Saved in:
| Title: | Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial. |
|---|---|
| Authors: | Shoham S; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Bloch EM; Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Casadevall A; Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Hanley D; Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Lau B; Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Gebo K; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Cachay E; Department of Medicine, Division of Infectious Diseases, University of California, San Diego, San Diego, California, USA., Kassaye SG; Division of Infectious Diseases/Department of Medicine, Georgetown University Medical Center, Washington D.C, USA., Paxton JH; Department of Emergency Medicine, Wayne State University, Detroit, Michigan, USA., Gerber J; Department of Medicine, Division of Hematology and Oncology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA., Levine AC; Department of Emergency Medicine, Rhode Island Hospital/Brown University, Providence, Rhode Island, USA., Naeim A; Department of Medicine, Division of Infectious Diseases, University of California, Los Angeles, Los Angeles, California, USA., Currier J; Department of Medicine, Division of Infectious Diseases, University of California, Los Angeles, Los Angeles, California, USA., Patel B; Department of Medicine, Division Critical Care Medicine, University of Texas Health, Houston, Texas, USA., Allen ES; Department of Pathology, University of California, San Diego, San Diego, California, USA., Anjan S; Department of Medicine, Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA., Appel L; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Baksh S; Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Blair PW; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Bowen A; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Broderick P; Department of Emergency Medicine, Danbury Hospital, Danbury, Connecticut, USA., Caputo CA; Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Cluzet V; Vassar Brothers Medical Center, Nuvance Health, Poughkeepsie, New York, USA., Cordisco ME; Office of Clinical Trials, Nuvance Health, University of Vermont, Danbury, Connecticut, USA., Cruser D; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Ehrhardt S; Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Forthal D; Department of Medicine, Division of Infectious Diseases, University of California, Irvine, Irvine, California, USA., Fukuta Y; Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, Texas, USA., Gawad AL; Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Gniadek T; Department of Pathology, Northshore University Health System, Evanston, Illinois, USA., Hammel J; Department of Emergency Medicine, Norwalk Hospital, Norwalk, Connecticut, USA., Huaman MA; Department of Medicine, Division of Infectious Diseases, University of Cincinnati, Cincinnati, Ohio, USA., Jabs DA; Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Jedlicka A; Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Karlen N; Mosaic Consulting Ltd., Israel., Klein S; Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Laeyendecker O; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Baltimore, Maryland, USA., Lane K; Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., McBee N; Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Meisenberg B; Department of Medicine, Luminis Health, Annapolis, Maryland, USA., Merlo C; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Mosnaim G; Division of Allergy and Immunology, Department of Medicine, Northshore University Health System, Evanston, Illinois, USA., Park HS; Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Pekosz A; Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Petrini J; Office of Clinical Trials, Nuvance Health, University of Vermont, Danbury, Connecticut, USA., Rausch W; Office of Clinical Trials, Nuvance Health, University of Vermont, Danbury, Connecticut, USA., Shade DM; Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Shapiro JR; Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Singleton JR; Department of Neurology, University of Utah, Salt Lake City, Utah, USA., Sutcliffe C; Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Thomas DL; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Yarava A; Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Zand M; Department of Medicine, University of Rochester, Rochester, New York, USA., Zenilman JM; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Tobian AAR; Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Sullivan DJ; Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Feb 08; Vol. 76 (3), pp. e477-e486. |
| Publication Type: | Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
